Clinical Trial Update: Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal Women [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating switching from oral bisphosphonates to bazedoxifene and its effects on bone mineral density in postmenopausal women; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Bazedoxifene (bazedoxifene)

Snippet

Sponsor: Instituto Palacios | Conditions: Osteoporosis, Postmenopausal | Phase 4 | Status: COMPLETED